DE69325450D1 - Potenzierung von antimikrobiellen wirkungen - Google Patents

Potenzierung von antimikrobiellen wirkungen

Info

Publication number
DE69325450D1
DE69325450D1 DE69325450T DE69325450T DE69325450D1 DE 69325450 D1 DE69325450 D1 DE 69325450D1 DE 69325450 T DE69325450 T DE 69325450T DE 69325450 T DE69325450 T DE 69325450T DE 69325450 D1 DE69325450 D1 DE 69325450D1
Authority
DE
Germany
Prior art keywords
pct
composition
preparation
monoglyceride
sec
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69325450T
Other languages
English (en)
Other versions
DE69325450T2 (de
Inventor
Karin Oelund
Lena-Karin Luetz
Richard Bryland
Ake Lindahl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jagotec AG
Original Assignee
Bioglan AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglan AB filed Critical Bioglan AB
Publication of DE69325450D1 publication Critical patent/DE69325450D1/de
Application granted granted Critical
Publication of DE69325450T2 publication Critical patent/DE69325450T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Plant Pathology (AREA)
  • Emergency Medicine (AREA)
  • Environmental Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Dentistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Communicable Diseases (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DE69325450T 1992-04-14 1993-03-31 Potenzierung von antimikrobiellen wirkungen Expired - Lifetime DE69325450T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9201187A SE500777C2 (sv) 1992-04-14 1992-04-14 Antimikrobiell komposition med potentierad effekt innehållande bl a vissa monoglycerider, förfarande för framställning därav samt användning därav
PCT/SE1993/000275 WO1993020812A1 (en) 1992-04-14 1993-03-31 Potentiation of antimicrobial effects

Publications (2)

Publication Number Publication Date
DE69325450D1 true DE69325450D1 (de) 1999-07-29
DE69325450T2 DE69325450T2 (de) 1999-12-23

Family

ID=20385960

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69325450T Expired - Lifetime DE69325450T2 (de) 1992-04-14 1993-03-31 Potenzierung von antimikrobiellen wirkungen

Country Status (15)

Country Link
US (1) US5550145A (de)
EP (1) EP0636024B1 (de)
JP (1) JP4014114B2 (de)
AT (1) ATE181502T1 (de)
AU (1) AU677580B2 (de)
CA (1) CA2118114C (de)
DE (1) DE69325450T2 (de)
DK (1) DK0636024T3 (de)
ES (1) ES2132230T3 (de)
GR (1) GR3030999T3 (de)
HK (1) HK1007923A1 (de)
NZ (1) NZ251783A (de)
SE (1) SE500777C2 (de)
SG (1) SG52341A1 (de)
WO (1) WO1993020812A1 (de)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4411899A1 (de) * 1994-04-07 1995-10-12 Beiersdorf Ag Gegen Fußgeruch wirksame Zubereitungen mit einem Gehalt an Monoglycerinestern von Fettsäuren
WO1995031966A1 (en) * 1994-05-20 1995-11-30 Novavax, Inc. Antimicrobial oil-in-water emulsions
US5460802A (en) * 1994-07-18 1995-10-24 Minnesota Mining And Manufacturing Company Oral disinfectant for companion animals
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
DE4434775A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäureglyceriden gegen Superinfektionen
DE4435290A1 (de) * 1994-10-01 1996-04-04 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
DE4436537A1 (de) * 1994-10-13 1996-04-18 Beiersdorf Ag Dermatologische Zubereitungen mit einem Gehalt an Fettsäuren und Fettsäureglyceriden gegen Superinfektionen
DE4438588A1 (de) * 1994-10-28 1996-05-02 Beiersdorf Ag Gegen unreine Haut, leichte Formen der Akne sowie Propionibacterium acnes wirksame Wirkstoffkombinationen auf der Basis von Wollwachssäuren und Glycerinestern gesättigter Fettsäuren
DE4444237C2 (de) * 1994-12-13 2000-08-24 Beiersdorf Ag Verwendung von Wirkstoffkombinationen zur Bekämpfung durch Propionibacterium acnes hervorgerufener unreiner Haut sowie leichter Formen der Akne
DE19540465A1 (de) * 1995-10-30 1997-05-07 Beiersdorf Ag Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden
US5700842A (en) * 1995-11-01 1997-12-23 Kimberly-Clark Worldwide, Inc. Methods of incorporating a hydrophobic substance into an aqueous solution
DE19541967A1 (de) * 1995-11-10 1997-05-15 Beiersdorf Ag Gegen Bakterien, Mycota und Viren wirksame Zusammensetzungen auf der Basis von Partialglyceriden und Arylverbindungen
EP0935960B1 (de) 1998-02-12 2001-05-30 L'oreal Verwendung von 1,2-Pentandiol in einer kosmetischen oder dermatologischen Zusammensetzung, welche filmbildende Polymerpartikel in wässriger Dispersion enthält und kosmetische oder dermatologische Zusammensetzung, enthaltend obige Bestandteile
RU2221557C2 (ru) 1998-03-19 2004-01-20 Бифодан А/С Дезинфицирующий состав
AU781957B2 (en) * 1998-06-23 2005-06-23 University Of Maryland Use of oils having a high lauric acid content as an animal feed
US6096332A (en) * 1998-06-30 2000-08-01 Mcneil-Ppc, Inc. Adding pharmaceutically active compounds to substrates
IT1317735B1 (it) * 2000-01-26 2003-07-15 Nicox Sa Sali di agenti antimicrobici.
US6429231B1 (en) * 2001-09-24 2002-08-06 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
US7074832B2 (en) 2001-09-24 2006-07-11 Bradley Pharmaceuticals, Inc. Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
SE0103528D0 (sv) * 2001-10-21 2001-10-21 Jan Faergeman Topiska kompositioner med förstärkt effekt
DE10205190B4 (de) 2002-02-08 2017-06-08 Beiersdorf Ag 2-Methyl-1,3-propandiol haltige Zubereitungen
US20050036972A1 (en) * 2003-03-10 2005-02-17 Hy-Gene Biomedical Corporation System for managing pathogens and irritants and monitoring usage of anti-bacterial formulations
US20050014932A1 (en) 2003-05-15 2005-01-20 Iogenetics, Llc Targeted biocides
US8394379B2 (en) * 2003-05-15 2013-03-12 Iogenetics, Llc Targeted cryptosporidium biocides
US7566447B2 (en) * 2003-05-15 2009-07-28 Iogenetics, Llc Biocides
US8703134B2 (en) 2003-05-15 2014-04-22 Iogenetics, Llc Targeted cryptosporidium biocides
JP4091566B2 (ja) * 2003-06-03 2008-05-28 株式会社マンダム 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品
SE0301862D0 (sv) * 2003-06-26 2003-06-26 Jan Faergeman Sätt att inhibera tillväxten av mot antibiotika resistenta bakterier
US7214391B2 (en) * 2003-06-30 2007-05-08 Usana Health Sciences, Inc. Botanical extract compositions and process for preparing same
MY140194A (en) * 2003-07-16 2009-11-30 Leo Pharma As Novel fusidic acid derivatives
KR101232924B1 (ko) * 2003-09-09 2013-02-13 쓰리엠 이노베이티브 프로퍼티즈 컴파니 농축된 항균 조성물 및 방법
EP1662873B1 (de) * 2003-09-09 2016-01-13 3M Innovative Properties Company Antimikrobielle zusammensetzunghen und verfahren
US20050058673A1 (en) * 2003-09-09 2005-03-17 3M Innovative Properties Company Antimicrobial compositions and methods
WO2005047475A2 (en) * 2003-11-11 2005-05-26 Regents Of The University Of Minnesota Regulation of cell membrane-mediated effects
FR2869802B1 (fr) * 2004-05-04 2010-08-20 I N E A S L Composition cosmetique et/ou dermatologique possedant des proprietes conservatrices hypoalergeniques
US8796332B2 (en) 2004-08-03 2014-08-05 Regents Of The University Of Minnesota Compositions and methods for controlling infections
WO2006132665A2 (en) * 2004-10-20 2006-12-14 Iogenetics, Llc Biocides
US20060127437A1 (en) * 2004-12-13 2006-06-15 Misty Anderson Kennedy Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
US20070059350A1 (en) * 2004-12-13 2007-03-15 Kennedy John P Agents for controlling biological fluids and methods of use thereof
US8535709B2 (en) * 2004-12-13 2013-09-17 Southeastern Medical Technologies, Llc Agents for controlling biological fluids and methods of use thereof
US8476319B2 (en) 2005-03-10 2013-07-02 3M Innovative Properties Company Methods of treating ear infections
MX2007010906A (es) 2005-03-10 2007-12-05 3M Innovative Properties Co Metodos para reducir la contaminacion microbiana.
US20060204558A1 (en) * 2005-03-10 2006-09-14 Kantner Steven S Antimicrobial pet wipes and methods
BRPI0608691A2 (pt) 2005-03-10 2010-12-07 3M Innovative Properties Co composição antimicrobiana, e, métodos para matar ou inativar microorganismos em tecido da mucosa de um mamìfero, para tratar uma lesão ou ferimento infectado, para descolonização de microorganismos, para proporcionar eficácia antimicrobiana residual sobre uma superfìcie e para tratar uma condição
US20060229364A1 (en) * 2005-03-10 2006-10-12 3M Innovative Properties Company Antiviral compositions and methods of use
WO2007087806A1 (en) * 2006-02-02 2007-08-09 Leo Pharma A/S A topical composition comprising an antibacterial substance
US20080075793A1 (en) * 2006-09-21 2008-03-27 Dunshee Wayne K Antiviral compositions and methods of use
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
FR2954124B1 (fr) * 2009-12-18 2012-04-06 Fabre Pierre Dermo Cosmetique Utilisation du 2,3-dihydroxypropyl dodecanoate pour le traitement de la seborrhee
US20130165880A1 (en) 2010-09-17 2013-06-27 David T. Amos Antimicrobial disposable absorbent articles
EP2643003B1 (de) * 2011-04-29 2014-12-17 Effik International S.A. Vaginale zusammensetzung auf basis von alkylpolyglukosiden
GB201118193D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to oranic compounds
GB201118198D0 (en) 2011-10-21 2011-12-07 Jagotec Ag Improvements in or relating to organic compounds
KR20190037229A (ko) * 2016-06-13 2019-04-05 바이옴 테라퓨틱스 리미티드 상승효과적 항진균 조성물 및 그의 방법
WO2017216722A2 (en) * 2016-06-13 2017-12-21 Vyome Biosciences Pvt. Ltd. Synergistic antifungal compositions and methods thereof

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK116528A (de) * 1966-09-30
US4067997A (en) * 1975-05-21 1978-01-10 Med-Chem Laboratories Synergistic microbecidal composition and method
JPS5814758B2 (ja) * 1977-08-23 1983-03-22 株式会社日立製作所 多層配線基板
JPS58111669A (ja) * 1981-12-25 1983-07-02 Takeda Chem Ind Ltd 食品用防腐剤および食品の防腐方法
CA1331559C (en) * 1986-04-21 1994-08-23 Jon Joseph Kabara Antimicrobial preservative compositions and methods
CA1302280C (en) * 1986-04-21 1992-06-02 Jon Joseph Kabara Topical antimicrobial pharmaceutical compositions and methods
NZ221168A (en) * 1986-08-15 1989-08-29 Colgate Palmolive Co Antiseptic composition containing ethyl alcohol and monolaurin
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides
US4847088A (en) * 1988-04-28 1989-07-11 Dow Corning Corporation Synergistic antimicrobial composition
EP0839529A3 (de) * 1989-03-13 2000-03-22 Cellegy Pharmaceuticals, Inc. Zubereitungen enthaltend Ester oder Amide von alipatischen Monocarbonsäuren zur Behandlung von Hautkrankheiten
US5057500A (en) * 1990-02-12 1991-10-15 Dermatologic Research Corporation Treatment of pruritis with esters and amides
DK0593459T3 (da) * 1990-04-18 1997-07-21 Procter & Gamble Sammensætninger til behandling mod lus
FI912955A (fi) * 1990-06-25 1991-12-26 Res Found Mental Hygiene Antimikroba fettsyrasammansaettningar.
NZ250714A (en) * 1990-10-30 1996-05-28 Mcneil Ppc Inc Liquid composition comprising esters of higher fatty acids for use as a vaginal douche and to prevent toxic shock toxin production

Also Published As

Publication number Publication date
SG52341A1 (en) 1998-09-28
HK1007923A1 (en) 1999-04-30
NZ251783A (en) 1996-07-26
ES2132230T3 (es) 1999-08-16
ATE181502T1 (de) 1999-07-15
JP4014114B2 (ja) 2007-11-28
GR3030999T3 (en) 1999-12-31
DE69325450T2 (de) 1999-12-23
US5550145A (en) 1996-08-27
DK0636024T3 (da) 1999-11-22
EP0636024B1 (de) 1999-06-23
AU3963993A (en) 1993-11-18
WO1993020812A1 (en) 1993-10-28
CA2118114A1 (en) 1993-10-28
EP0636024A1 (de) 1995-02-01
CA2118114C (en) 2003-06-17
SE9201187D0 (sv) 1992-04-14
JPH07505880A (ja) 1995-06-29
SE9201187L (sv) 1993-10-15
SE500777C2 (sv) 1994-08-29
AU677580B2 (en) 1997-05-01

Similar Documents

Publication Publication Date Title
DE69325450T2 (de) Potenzierung von antimikrobiellen wirkungen
CA1250522A (en) Skin care compositions
IL87488A0 (en) Pharmaceutical compositions for the topical treatment of conditions associated with photodamaged skin,comprising substituted propenyl phenyl derivatives
DE69533593D1 (de) Zubereitungen zur behandlung von gastrointestinalen störungen, welche arabinogalactan und polyphenole von larix enthalten.
ZA867386B (en) Pharmaceutical and dietary composition
EP0222483A3 (en) Use of gamma-linolenic acid and related compounds in the treatment of endometriosis
BG60261B2 (en) Lon-acting formulation of cefaclor
FR2681784B1 (fr) Composition dermatologique et/ou cosmetologique contenant des retinouides et utilisation de nouveaux retinouides.
GEP20002068B (en) Antimicrobial Compositions Containing a C3-C6 Alcohol
DE69508918T2 (de) Synergistische antimikrobielle zusammensetzung die methylen-bis-thiocyanat enthält
UA41285C2 (uk) Креатин фосфат і його фармацевтично прийнятні солі для лікування пухлин та фармацевтична композиція, що має протипухлинну активність
GB1474424A (en) Pharmaceutical composition for treating diabetic ketoacidosis
MD1762B2 (ro) Derivaţi de pirazoliloxipiridină, procedeu de obţinere a lor, compoziţie erbicidă, procedeu de combatere a plantelor indezirabile
JPH03157311A (ja) にきび用化粧料
GB2094623A (en) Compositions containing hydrogen peroxide
IL90528A0 (en) Propanolamine derivatives,their preparation and pharmaceutical compositions containing them
CA1102238A (en) Composition for treating burns
SE9302006D0 (sv) Protein formulation
ES2059594T3 (es) Peptidos con actividad inhibidora de sistemas enzimaticos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
JPS6160676A (ja) Ｎ−シクロヘキシル−ｎ−メトキシ−２，５−ジメチルフラン−３−カルボキサミドの安定化方法
GEP20002241B (en) Polymorphs and Hydrated Forms of Lesopitron Dichlorohydrate, Methods for Its Preparation and Pharmaceutical Compositions Containing Same
TH14341EX (th) สารอาหารหรือสูตรผสมยาสำหรับการให้สู่ร่างกายของสัตว์เคี้ยวเอื้อง
GB1472816A (en) Circulatory pharmaceutical compositions containing tetrahydroal stonine
JPH0489417A (ja) コロミン酸含有化粧料
KR840002609A (ko) 살균성 조성물 및 세균의 성장에 저항하는 방법

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: JAGOTEC AG, MUTTENZ, CH